15-75904537-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_147188.3(FBXO22):c.187C>T(p.His63Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000416 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_147188.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO22 | NM_147188.3 | c.187C>T | p.His63Tyr | missense_variant | 2/7 | ENST00000308275.8 | NP_671717.1 | |
FBXO22 | NM_012170.4 | c.187C>T | p.His63Tyr | missense_variant | 2/6 | NP_036302.1 | ||
FBXO22 | NR_037623.2 | n.226+434C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO22 | ENST00000308275.8 | c.187C>T | p.His63Tyr | missense_variant | 2/7 | 1 | NM_147188.3 | ENSP00000307833.3 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251258Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135808
GnomAD4 exome AF: 0.000432 AC: 631AN: 1461508Hom.: 0 Cov.: 32 AF XY: 0.000409 AC XY: 297AN XY: 727022
GnomAD4 genome AF: 0.000263 AC: 40AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74420
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.187C>T (p.H63Y) alteration is located in exon 2 (coding exon 2) of the FBXO22 gene. This alteration results from a C to T substitution at nucleotide position 187, causing the histidine (H) at amino acid position 63 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at